CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis
Europe - Euronext Oslo - OSL:CONTX - SE0014731154 - Common Stock
4.09 NOK
-0.21 (-4.88%)
Taking everything into account, CONTX scores 6 out of 10 in our fundamental rating. CONTX was compared to 11 industry peers in the Health Care Technology industry. CONTX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CONTX has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
CONTX had positive earnings in the past year.
In the past year CONTX had a positive cash flow from operations.
CONTX had positive earnings in 4 of the past 5 years.
In the past 5 years CONTX always reported a positive cash flow from operatings.
1.2 Ratios
CONTX's Return On Assets of 7.66% is fine compared to the rest of the industry. CONTX outperforms 63.64% of its industry peers.
Looking at the Return On Equity, with a value of 10.25%, CONTX is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
With a decent Return On Invested Capital value of 8.96%, CONTX is doing good in the industry, outperforming 72.73% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CONTX is significantly above the industry average of 9.28%.
The 3 year average ROIC (36.72%) for CONTX is well above the current ROIC(8.96%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.66% | ||
| ROE | 10.25% | ||
| ROIC | 8.96% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
1.3 Margins
CONTX has a Profit Margin of 7.86%. This is in the better half of the industry: CONTX outperforms 63.64% of its industry peers.
CONTX's Profit Margin has improved in the last couple of years.
CONTX has a better Operating Margin (9.33%) than 63.64% of its industry peers.
CONTX's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 97.46%, CONTX belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
CONTX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.33% | ||
| PM (TTM) | 7.86% | ||
| GM | 97.46% |
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CONTX is creating value.
Compared to 1 year ago, CONTX has about the same amount of shares outstanding.
Compared to 5 years ago, CONTX has about the same amount of shares outstanding.
The debt/assets ratio for CONTX is higher compared to a year ago.
2.2 Solvency
The Debt to FCF ratio of CONTX is 1.49, which is an excellent value as it means it would take CONTX, only 1.49 years of fcf income to pay off all of its debts.
CONTX has a Debt to FCF ratio of 1.49. This is in the better half of the industry: CONTX outperforms 63.64% of its industry peers.
A Debt/Equity ratio of 0.07 indicates that CONTX is not too dependend on debt financing.
CONTX has a better Debt to Equity ratio (0.07) than 72.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 1.49 | ||
| Altman-Z | N/A |
ROIC/WACC1.26
WACC7.09%
2.3 Liquidity
CONTX has a Current Ratio of 4.12. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
CONTX has a Current ratio of 4.12. This is amongst the best in the industry. CONTX outperforms 90.91% of its industry peers.
A Quick Ratio of 4.07 indicates that CONTX has no problem at all paying its short term obligations.
The Quick ratio of CONTX (4.07) is better than 90.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.12 | ||
| Quick Ratio | 4.07 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 14.32% over the past year.
CONTX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 40.02% yearly.
Looking at the last year, CONTX shows a quite strong growth in Revenue. The Revenue has grown by 12.19% in the last year.
Measured over the past years, CONTX shows a small growth in Revenue. The Revenue has been growing by 7.78% on average per year.
EPS 1Y (TTM)14.32%
EPS 3Y40.02%
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y11.74%
Revenue growth 5Y7.78%
Sales Q2Q%-21.24%
3.2 Future
Based on estimates for the next years, CONTX will show a very negative growth in Earnings Per Share. The EPS will decrease by -13.34% on average per year.
CONTX is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.19% yearly.
EPS Next Y-28.88%
EPS Next 2Y-42.29%
EPS Next 3Y-35.39%
EPS Next 5Y-13.34%
Revenue Next Year-5.88%
Revenue Next 2Y-11.72%
Revenue Next 3Y-6.27%
Revenue Next 5Y-1.19%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 8.89 indicates a reasonable valuation of CONTX.
Based on the Price/Earnings ratio, CONTX is valued cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.61, CONTX is valued rather cheaply.
CONTX is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.89 | ||
| Fwd PE | N/A |
4.2 Price Multiples
CONTX's Enterprise Value to EBITDA ratio is in line with the industry average.
CONTX's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 49.15 | ||
| EV/EBITDA | 12.67 |
4.3 Compensation for Growth
The excellent profitability rating of CONTX may justify a higher PE ratio.
A cheap valuation may be justified as CONTX's earnings are expected to decrease with -35.39% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-42.29%
EPS Next 3Y-35.39%
5. Dividend
5.1 Amount
CONTX has a Yearly Dividend Yield of 4.18%, which is a nice return.
CONTX's Dividend Yield is rather good when compared to the industry average which is at 2.30. CONTX pays more dividend than 81.82% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.87, CONTX pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y-42.29%
EPS Next 3Y-35.39%
OSL:CONTX (12/23/2025, 4:03:30 PM)
4.09
-0.21 (-4.88%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners24%
Ins Owner ChangeN/A
Market Cap316.44M
Revenue(TTM)132.19M
Net Income(TTM)9.36M
Analysts40
Price Target4.08 (-0.24%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-124.27%
Min EPS beat(2)-148.54%
Max EPS beat(2)-100%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-17.12%
Min Revenue beat(2)-29.34%
Max Revenue beat(2)-4.91%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-20%
PT rev (3m)-20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)-104.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-11.52%
Revenue NY rev (3m)-11.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.89 | ||
| Fwd PE | N/A | ||
| P/S | 2.43 | ||
| P/FCF | 49.15 | ||
| P/OCF | 21.2 | ||
| P/B | 3.16 | ||
| P/tB | 3.26 | ||
| EV/EBITDA | 12.67 |
EPS(TTM)0.46
EY11.25%
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)0.08
FCFY2.03%
OCF(TTM)0.19
OCFY4.72%
SpS1.69
BVpS1.29
TBVpS1.25
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.66% | ||
| ROE | 10.25% | ||
| ROCE | 11.34% | ||
| ROIC | 8.96% | ||
| ROICexc | 31.76% | ||
| ROICexgc | 35.3% | ||
| OM | 9.33% | ||
| PM (TTM) | 7.86% | ||
| GM | 97.46% | ||
| FCFM | 4.93% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
ROICexc(3y)120.16%
ROICexc(5y)134.4%
ROICexgc(3y)169.64%
ROICexgc(5y)243.25%
ROCE(3y)46.47%
ROCE(5y)60.03%
ROICexgc growth 3Y-39.35%
ROICexgc growth 5Y-1.08%
ROICexc growth 3Y-26.11%
ROICexc growth 5Y14.23%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
F-Score5
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 1.49 | ||
| Debt/EBITDA | 0.34 | ||
| Cap/Depr | 96.94% | ||
| Cap/Sales | 6.51% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 71.3% | ||
| Profit Quality | 62.81% | ||
| Current Ratio | 4.12 | ||
| Quick Ratio | 4.07 | ||
| Altman-Z | N/A |
F-Score5
WACC7.09%
ROIC/WACC1.26
Cap/Depr(3y)55.3%
Cap/Depr(5y)58.55%
Cap/Sales(3y)3.81%
Cap/Sales(5y)5.04%
Profit Quality(3y)103.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.32%
EPS 3Y40.02%
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-28.88%
EPS Next 2Y-42.29%
EPS Next 3Y-35.39%
EPS Next 5Y-13.34%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y11.74%
Revenue growth 5Y7.78%
Sales Q2Q%-21.24%
Revenue Next Year-5.88%
Revenue Next 2Y-11.72%
Revenue Next 3Y-6.27%
Revenue Next 5Y-1.19%
EBIT growth 1Y-64.61%
EBIT growth 3Y-12.49%
EBIT growth 5Y8.23%
EBIT Next Year-25%
EBIT Next 3Y6.69%
EBIT Next 5YN/A
FCF growth 1Y-82.88%
FCF growth 3Y82.69%
FCF growth 5Y67.13%
OCF growth 1Y-68.39%
OCF growth 3Y51.49%
OCF growth 5Y5.6%
CONTEXTVISION AB / CONTX.OL FAQ
What is the ChartMill fundamental rating of CONTEXTVISION AB (CONTX.OL) stock?
ChartMill assigns a fundamental rating of 6 / 10 to CONTX.OL.
What is the valuation status of CONTEXTVISION AB (CONTX.OL) stock?
ChartMill assigns a valuation rating of 4 / 10 to CONTEXTVISION AB (CONTX.OL). This can be considered as Fairly Valued.
How profitable is CONTEXTVISION AB (CONTX.OL) stock?
CONTEXTVISION AB (CONTX.OL) has a profitability rating of 8 / 10.
How financially healthy is CONTEXTVISION AB?
The financial health rating of CONTEXTVISION AB (CONTX.OL) is 7 / 10.
Can you provide the expected EPS growth for CONTX stock?
The Earnings per Share (EPS) of CONTEXTVISION AB (CONTX.OL) is expected to decline by -28.88% in the next year.